<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/" xmlns:admin="http://webns.net/mvcb/">
<channel rdf:about="https://thescipub.com/feed/aji/issue-194.rss">
<title>Volume 5, Issue 1 (2009) | American Journal of Immunology</title>
<description>Volume 5, Issue 1 (2009) | American Journal of Immunology</description>
<link>https://thescipub.com/aji/issue/194</link>
<admin:generatorAgent rdf:resource="https://thescipub.com/"/>
<admin:errorReportsTo rdf:resource="mailto:support@thescipub.com"/>
<dc:publisher>Science Publications</dc:publisher>
<dc:language>en</dc:language>
<prism:publicationName>Science Publications</prism:publicationName>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2009.1.7"/><rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2009.8.16"/><rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2009.17.28"/><rdf:li rdf:resource="https://thescipub.com/aji/ajisp.2009.29.49"/></rdf:Seq>
</items>
</channel><item rdf:about="https://thescipub.com/aji/ajisp.2009.1.7">
    <title><![CDATA[Clinical Evidence of Autologous Graft versus Tumor Effect]]></title>
    <link>https://thescipub.com/aji/ajisp.2009.1.7</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 January 2009; <a href="https://thescipub.com/aji/ajisp.2009.1.7">doi:10.3844/ajisp.2009.1.7</a></p>Problem statement: The infused alloreactive lymphocytes in allogeneic 
stem cell transplantation (Allo-SCT) lead to an unspecific immune response causing 
Graft-Versus-Tumor (GVT) effect and Graft-V...]]></content:encoded>
    <dc:title><![CDATA[Clinical Evidence of Autologous Graft versus Tumor Effect]]></dc:title><dc:creator>Luis F. Porrata</dc:creator><dc:identifier>doi:10.3844/ajisp.2009.1.7</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2009-01-31; | doi:10.3844/ajisp.2009.1.7</dc:source>
    <dc:date>2009-01-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2009.1.7</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2009.1.7</prism:url>
    </item><item rdf:about="https://thescipub.com/aji/ajisp.2009.8.16">
    <title><![CDATA[Cancer Chemotherapy and Immune Regulation]]></title>
    <link>https://thescipub.com/aji/ajisp.2009.8.16</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 March 2009; <a href="https://thescipub.com/aji/ajisp.2009.8.16">doi:10.3844/ajisp.2009.8.16</a></p>Problem statement: Chemotherapeutic drugs have been used to treat 
malignancy for over 50 years, but the potential of cytotoxic agents to suppress 
immunity and interfere with Immunosurveillance (IS...]]></content:encoded>
    <dc:title><![CDATA[Cancer Chemotherapy and Immune Regulation]]></dc:title><dc:creator>John  Barrett</dc:creator><dc:creator>Katarina Le Blanc</dc:creator><dc:identifier>doi:10.3844/ajisp.2009.8.16</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2009-03-31; | doi:10.3844/ajisp.2009.8.16</dc:source>
    <dc:date>2009-03-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2009.8.16</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2009.8.16</prism:url>
    </item><item rdf:about="https://thescipub.com/aji/ajisp.2009.17.28">
    <title><![CDATA[The Role of T<sub>reg</sub> Cells in the Cancer Immunological Response]]></title>
    <link>https://thescipub.com/aji/ajisp.2009.17.28</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 March 2009; <a href="https://thescipub.com/aji/ajisp.2009.17.28">doi:10.3844/ajisp.2009.17.28</a></p>Problem statement: T cell-mediated immunosuppression has been 
observed for decades without clarification as to which factor was responsible 
for this observation. The identification of CD4+CD25+ re...]]></content:encoded>
    <dc:title><![CDATA[The Role of T<sub>reg</sub> Cells in the Cancer Immunological Response]]></dc:title><dc:creator>Zhi-Zhang  Yang</dc:creator><dc:creator>Stephen M. Ansell</dc:creator><dc:identifier>doi:10.3844/ajisp.2009.17.28</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2009-03-31; | doi:10.3844/ajisp.2009.17.28</dc:source>
    <dc:date>2009-03-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2009.17.28</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2009.17.28</prism:url>
    </item><item rdf:about="https://thescipub.com/aji/ajisp.2009.29.49">
    <title><![CDATA[The Tumor/Immune Interface: Clinical Evidence of Cancer Immunosurveillance, Immunoediting and Immunosubversion]]></title>
    <link>https://thescipub.com/aji/ajisp.2009.29.49</link>
    <content:encoded>
        <![CDATA[<p>American Journal of Immunology, Published online: 31 March 2009; <a href="https://thescipub.com/aji/ajisp.2009.29.49">doi:10.3844/ajisp.2009.29.49</a></p>Problem statement: The interactions of a malignant tumor with 
the patient’s immune system are dynamic, multiple and bi-directional. Approach: This article reviews the clinical evidence of the inte...]]></content:encoded>
    <dc:title><![CDATA[The Tumor/Immune Interface: Clinical Evidence of Cancer Immunosurveillance, Immunoediting and Immunosubversion]]></dc:title><dc:creator>Matthew S. Block</dc:creator><dc:creator>Svetomir N. Markovic</dc:creator><dc:identifier>doi:10.3844/ajisp.2009.29.49</dc:identifier>
    <dc:source>American Journal of Immunology, Published online: 2009-03-31; | doi:10.3844/ajisp.2009.29.49</dc:source>
    <dc:date>2009-03-31</dc:date>
    <prism:publicationName>Science Publications</prism:publicationName>
    <prism:doi>10.3844/ajisp.2009.29.49</prism:doi>
    <prism:url>https://thescipub.com/aji/ajisp.2009.29.49</prism:url>
    </item></rdf:RDF>